Thailand confirms first parrot fever case and urges caution among bird owners

BANGKOK: It has become a hot topic that has animal lovers and the public on alert after the Ministry of Digital Economy and ...

SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

ARBLI ™ is the first and only oral liquid formulation of losartan approved by the U.S. FDA. ARBLI ™ comes in a 165 mL bottle as a peppermint flavored suspension that does not require refrigeration, ...

Scienture Holdings, Inc.: SCIENTURE Provides Commercial Update on ARBLI, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

Company highlights accelerating access and revenue growth for ARBLI and confirms REZENOPY launch timeline, addressing a combined US annual losartan and naloxone market size of close to $385 million Ou ...

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ) in Adults and Adolescents With Vitiligo

Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
The Cardiology Advisor

AAP Issues Updated Childhood and Adolescent Immunization Schedule

The recommended childhood and adolescent immunization schedule for the United States for 2026 has been issued by the AAP.